Evidence map›Paper›PMID 41261853›Full record

ArticleNucleic acids research2025

Molecular basis of tRNA aminocarboxypropyl-transferase TapT for substrate recognition.

Wei-Yan Wang, Heng-Rui Liang, Yu-Cong Wu, Ping-Wei Liu, Zhu Wang, Yi-Yang Jiang, Hai-Xue Pan, Gong-Li Tang, Jin-Yue Pu, Ai-Ai Sun

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei-Yan WangKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Heng-Rui LiangKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Yu-Cong WuKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Ping-Wei LiuKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Zhu WangKey Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Yi-Yang JiangDepartment of Hepatobiliary Surgery, Innovative Institute of Tumor Immunity and Medicine, Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Hai-Xue PanKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Gong-Li TangKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.ORCID 0000-0003-3149-4683
Jin-Yue PuKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
Ai-Ai SunKey Laboratory of Glyco-drug Research of Zhejiang Province, School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.ORCID 0000-0001-7109-6183

Funding

Natural Science Foundation of China 22137009Natural Science Foundation of China 32000846Natural Science Foundation of China 32201209
6 · The paper itself

Abstract

3-(3-amino-3-carboxypropyl) uridine (acp3U) is a highly conserved modification found in variable- and D-loops of transfer RNAs (tRNAs) in bacteria and eukarya. TapT has been identified as the enzyme responsible for acp3U modification at position 47 of Escherichia coli tRNAs in the presence of S-adenosylmethionine (SAM), while the specific substrate binding details and catalytic mechanism of TapT remain unknown. Here, we determined the three-dimensional structure of TapT in a SAM-bound state. The overall structure adopts SPOUT folding, with SAM located in an adaptive pocket. The cofactor recognition mode was further evaluated by additional structures of S-methyl-5'-thioadenosine or sinefungin to TapT, together with isothermal titration calorimetry to explore binding affinity and liquid chromatography-mass spectrometry experiments to detect enzymatic activity. Furthermore, we performed fluorescence polarization assays to explore the tRNA recognition mechanism of TapT. It thus provides a thorough molecular basis for TapT substrate recognition and may promote further application in biochemistry, molecular biology, and tumor diagnostics.

Indexed as

Escherichia coli ProteinsRNA, TransferAdenosineBinding SitesEscherichia coliModels, MolecularProtein BindingS-AdenosylmethionineSubstrate SpecificityAdenosineEscherichia coli ProteinsRNA, TransferS-Adenosylmethionine

Identifiers

PMID41261853
PMCPMC12630136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.